Growth Metrics

Jazz Pharmaceuticals (JAZZ) Goodwill & Intangibles (2016 - 2025)

Jazz Pharmaceuticals has reported Goodwill & Intangibles over the past 16 years, most recently at $6.3 billion for Q4 2025.

  • Quarterly Goodwill & Intangibles fell 3.29% to $6.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 billion through Dec 2025, down 3.29% year-over-year, with the annual reading at $6.3 billion for FY2025, 3.29% down from the prior year.
  • Goodwill & Intangibles was $6.3 billion for Q4 2025 at Jazz Pharmaceuticals, down from $6.4 billion in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $9.5 billion in Q2 2021 and troughed at $1.9 billion in Q3 2021.
  • The 5-year median for Goodwill & Intangibles is $7.0 billion (2024), against an average of $6.6 billion.
  • Biggest five-year swings in Goodwill & Intangibles: soared 830.8% in 2021 and later plummeted 66.53% in 2023.
  • Tracing JAZZ's Goodwill & Intangibles over 5 years: stood at $9.0 billion in 2021, then fell by 16.62% to $7.5 billion in 2022, then plummeted by 66.53% to $2.5 billion in 2023, then surged by 158.3% to $6.5 billion in 2024, then dropped by 3.29% to $6.3 billion in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $6.3 billion, $6.4 billion, and $6.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.